TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
VTR

Ventas Inc

Real Estate · REIT - Healthcare Facilities

87.70$ -0.6% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Ventas Inc (VTR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.5% of the shares are freely tradable; institutional investors hold 106.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 106.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 99.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 513Mio.

Largest Shareholders

Institutions

Institutions VTR
Name Stake (%) Shares Change (%) Date
BlackRock Inc 11.03 56,582,774 +2.7 03/31/2026
Vanguard Portfolio Management, LLC 8.04 41,261,965 +0.0 03/31/2026
JPMorgan Chase & Co 6.90 35,379,149 +25.8 03/31/2026
Vanguard Capital Management, LLC 6.02 30,866,845 +0.0 03/31/2026
State Street Corp 5.81 29,798,498 +0.5 03/31/2026
FMR Inc 5.31 27,251,339 -6.9 03/31/2026
Principal Financial Group Inc 2.72 13,969,657 -8.9 06/30/2026
Geode Capital Management, LLC 2.63 13,501,043 +3.9 03/31/2026

Funds

Funds VTR
Name Stake (%) Shares Change (%) Date
Vanguard Real Estate Index Investor 3.53 18,088,066 +0.0 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.02 15,477,527 +0.3 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings VTR
Person Role Shares Value As of Type
Lustig Matthew J Director 95,735 8,395,934 $ Jul 16, 2026 direct
Martino Roxanne M Director 66,846 5,862,367 $ Jul 16, 2026 direct
Barnes Melody C Director 35,379 3,102,701 $ Jul 16, 2026 direct
Smith Maurice S Director 31,311 2,746,007 $ Jul 16, 2026 direct
Roy Sumit Director 24,872 2,181,231 $ Jul 16, 2026 direct
Nader Marguerite M Director 23,544 2,064,771 $ Jul 16, 2026 direct
Embler Michael J Director 19,274 1,690,292 $ Jul 16, 2026 direct
Wattula Andy EVP OM&R-Ventas/Pres&CEO-LHS 15,008 1,316,202 $ Aug 1, 2026 direct
Rodriguez Joe Vasquez Jr. Director 9,943 872,021 $ Jul 16, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 1, 2026 Wattula Andy EVP OM&R-Ventas/Pres&CEO-LHS Other 4,314 93.51 403,402
Aug 1, 2026 Wattula Andy EVP OM&R-Ventas/Pres&CEO-LHS Other 10,694 93.51 999,996
Jul 16, 2026 Rodriguez Joe Vasquez Jr. Director Other 49 95.04 4,657
Jul 16, 2026 Smith Maurice S Director Other 72 95.04 6,843
Jul 16, 2026 Smith Maurice S Director Other 56 95.04 5,322
Jul 16, 2026 Martino Roxanne M Director Other 174 95.04 16,537
Jul 16, 2026 Barnes Melody C Director Other 72 95.04 6,843
Jul 16, 2026 Roy Sumit Director Other 72 95.04 6,843
Jul 16, 2026 Roy Sumit Director Other 47 95.04 4,467
Jul 16, 2026 Nader Marguerite M Director Other 72 95.04 6,843
Jul 16, 2026 Embler Michael J Director Other 72 95.04 6,843
Jul 16, 2026 Lustig Matthew J Director Other 72 95.04 6,843
Jul 16, 2026 Lustig Matthew J Director Other 210 95.04 19,958

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?